MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix
MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix
复制标题
MicroRNA-214 通过靶向 Osterix 抑制 C2C12 成肌细胞的成骨分化
DOI:
10.1016/j.bone.2013.04.002
复制
发表时间:
2013-08-01
期刊:
影响因子:
4.1
通讯作者:
Ma, Changyan
中科院分区:
文献类型:
--
作者:
Shi, Kaikai;Lu, Jianlei;Ma, Changyan
Osterix (Osx) is an osteoblast-specific transcription factor that is essential for osteoblast differentiation and bone formation. Osx-null mice, which exhibit a complete absence of bone formation and arrested osteoblast differentiation, die immediately after birth. However, our understanding of the regulatory mechanism of Osx expression remains poor. MicroRNAs (miRNAs) are a class of small non-coding RNAs that play pivotal Riles in diverse biological processes, including the development, differentiation, proliferation, survival, and oncogenesis of cells and organisms. In this study, we aimed to investigate the impact of miRNAs on Osx expression. Bioinformatic analyses predicted that miR-214 would be a potential regulator of Osx. The direct binding of miR-214 to the Osx 3' untranslated region (3' UTR) was demonstrated by a luciferase reporter assay using a construct containing the Osx 3' UTR. Deletion mutant construction revealed that the Osx 3' UTR contained two miR-214 binding sites. MiR-214 expression was inversely correlated with Osx expression in Saos-2 and U2OS cells. The forced expression of miR-214 in Saos-2 cells led to a reduction in the level of Osx protein. Moreover, the role of miR-214 in the osteogenic differentiation of C2C12 cells was investigated. We found that the osteogenic differentiation of C2C12 cells was enhanced by the downregulation of miR-214 expression, as measured by increased alkaline phosphatase activity and matrix mineralization. Taken together, these results indicate that miR-214 is a novel regulator of Osx, and that it plays an important role in the osteogenic differentiation of C2C12 cells as a suppressor. (C)2013 Elsevier Inc. All rights reserved.